RedHill Biopharma Ltd.: Strategic Expansion from R&D to Sales of Drugs in the US jaimeuss_admin 17 בSeptember 2018 Research 0 Comments Continue Reading
Kadimastem offers treatment of diabetes and neurological diseases such as ALS by cellular therapy; Company is pursuing clinical trial (ALS), and pre-clinical processes (diabetes); target price set at NIS 0.85 jaimeuss_admin 16 בSeptember 2018 Research 0 Comments Continue Reading
Oramed Pharmaceuticals (PRNewsFoto/Oramed Pharmaceuticals Inc) Oramed Pharmaceuticals Inc.: An emerging player in the huge orally delivered therapeutics segment of the global diabetes care market; we initiate our coverage with a price target of NIS 53.2 jaimeuss_admin 6 בSeptember 2018 Research 0 Comments Continue Reading
Enlight Renewable Energy Ltd.: The Company may double its revenues within two years; price target is NIS 2.30. jaimeuss_admin 6 בSeptember 2018 Research 0 Comments Continue Reading
Energix Renewable Energies Ltd.: Combining green energy growth opportunities with Fix Assets returns jaimeuss_admin 6 בSeptember 2018 Research 0 Comments Continue Reading
DNA Biomedical Solutions Ltd.: The company and its holdings can become a major force in the osteoporosis care market, pending success in next year’s clinical trials. jaimeuss_admin 6 בSeptember 2018 Research 0 Comments Continue Reading
Vonetize Plc: An Investment Opportunity in the Fast-Growing VOD/IPTV Domain jaimeuss_admin 30 בAugust 2018 Research 0 Comments Continue Reading
Brainsway Ltd.: Market Trends Drive Revenue Growth. An Opportunity for Increased Value based on the scenario of the Successful Execution of the New Business Model jaimeuss_admin 30 בAugust 2018 Research 0 Comments Continue Reading
BiolineRx. An Opportunity to Invest in the Development of Unique Cancer Treatment Technologies jaimeuss_admin 30 בAugust 2018 Research 0 Comments Continue Reading